Executive Summary

StemCells, Inc. is focused on the discovery and development of stem cell therapeutics that will form the basis of therapies to support or replace cells that have been damaged or lost through disease, injury or genetic defect. Initially, we are focussing on such conditions in the Central Nervous System, Liver and Pancreas.

We are a world leader in the discovery and development of human neural stem cell technology using cells derived from adult (i.e. non-embryonic) brain tissue.

We use a proprietary process to isolate, purify and expand rare candidate stem cells found in adult human tissue.

To date, we have discovered the human neural stem cell as well as a population of rare candidate stem cells found in human liver and pancreas.

We have over forty issued U.S. patents, plus foreign equivalents to some fourteen of our U.S. patents and applications, for a total of over one hundred and seventy individual patents worldwide.

Our scientific founders, who are also members of our Scientific Advisory Board, are recognized as world leaders in stem cell biology.